Antibiotic treatment alters the composition and metabolic function of the intestinal microbiota. These alterations may contribute to the pathogenesis of necrotizing enterocolitis (NEC) and antibiotic-associated diarrhea (AAD). Recent studies are beginning to unravel the contribution of specific groups of microbes and their metabolic pathways to these diseases. Probiotics or other microbiota-targeted therapies may provide effect strategies to prevent and treat NEC and AAD.
Keywords: Antibiotic-associated diarrhea; Antibiotics; Clostridium difficile; Microbiome; Necrotizing enterocolitis; Probiotics.
Copyright © 2016 Elsevier Inc. All rights reserved.